Polyclonal Antibodies

HIV 1 gp41 Antibody

HIV-1 gp41, Rabbit Polyclonal Antibody

This product is a rabbit serum solution containing antibodies that specifically target the HIV-1 protein, DEV-I. This protein is a recombinant form of the virus's envelope protein and comprises the C-terminal portion of gp120 and a significant part of gp41. It is produced in E. coli.
Shipped with Ice Packs
Cat. No.
BT4313
Appearance
A clear, sterile solution that has been passed through a filter.

HIV 2 gp39 Antibody

HIV-2 gp39, Polyclonal Rabbit Antibody

Antibody targeting the HIV-2 gp39 protein, produced in rabbits using a recombinant protein derived from E. coli.
Shipped with Ice Packs
Cat. No.
BT4445
Appearance
Sterile solution that has been filtered.

HIV-1 gp120 Antibody

HIV-1 gp120, Rabbit Antibody

This product is a purified antibody that is produced in rabbits. It specifically targets the HIV-1 gp120 protein.
Shipped with Ice Packs
Cat. No.
BT4549
Appearance
This product is a white powder that has been sterilized by filtration and freeze-dried.

Influenza B Antibody

Influenza-B Jiangsu/10/2003 Hemagglutinin, Rabbit Antibody

The Influenza Hemagglutinin protein is a key surface glycoprotein of the influenza B virus, playing a critical role in the virus's ability to attach to host cells. This antibody, targeting the hemagglutinin protein, was generated by immunizing rabbits with a purified recombinant form of the protein derived from the influenza B Jiangsu/10/2003 strain. The recombinant protein, produced using a baculovirus expression system in insect cells, was purified under stringent conditions to maintain its structural integrity and biological activity.
Shipped with Ice Packs
Cat. No.
BT4648

Zika Envelope Antibody

Polyclonal Rabbit Anti Zika envelope

To generate Zika envelope antibodies, the full-length Zika virus envelope DNA was cloned into a mammalian cell expression vector containing a recombinant promoter. This construct was then used to immunize rabbits, leading to the in vivo expression of the Zika envelope protein and subsequent production of specific antibodies. The resulting rabbit serum exhibited high titers of anti-Zika envelope antibodies, typically requiring a dilution of 1:4000 to 1:5000 before use.
Shipped with Ice Packs
Cat. No.
BT5072
Appearance
The antibody solution is a clear, colorless, and sterile-filtered liquid.

CoV2 Nucleocapsid Polyclonal

Full Length CoV2 Nucleocapsid, Polyclonal Antibody

Shipped with Ice Packs
Cat. No.
BT3629

Dengue 1 NS1 Antibody

Polyclonal Rabbit Anti Dengue 1 NS1

Polyclonal antibody to dengue-1 NS1 IgG was derived from the rabbit immunized with full length recombinant dengue NS1, reactive to all dengue serotype NS1.
Shipped with Ice Packs
Cat. No.
BT3687
Source
Rabbit.

Dengue 2 NS1 Antibody

Polyclonal Rabbit Anti Dengue 2 NS1

The polyclonal antibody to dengue serotype 2 NS1 was collected from the rabbit immunized with full length recombinant dengue serotype 2 NS1 antigen.
Shipped with Ice Packs
Cat. No.
BT3758

Dengue 3 NS1 Antibody

Polyclonal Rabbit Anti Dengue 3 NS1

This polyclonal antibody targets the dengue virus serotype 3 NS1 protein. It was generated by immunizing a rabbit with the full-length recombinant dengue serotype 3 NS1 antigen. This antibody exhibits reactivity to NS1 proteins from all dengue serotypes.
Shipped with Ice Packs
Cat. No.
BT3841
Source

Rabbit.

Definition and Classification

Antiviral agents are medications designed to treat viral infections by inhibiting the development and replication of viruses. Unlike antibiotics, which target bacteria, antivirals are specifically tailored to combat viruses. They can be classified into several categories based on their mechanism of action :

  • Nucleoside Analogs: These mimic the building blocks of viral DNA or RNA, disrupting the replication process.
  • Non-Nucleoside Polymerase Inhibitors: These inhibit viral polymerase enzymes, preventing the synthesis of viral genetic material.
  • Protease Inhibitors: These block viral protease enzymes, which are essential for viral replication.
  • Entry Inhibitors: These prevent viruses from entering host cells.
  • Uncoating Inhibitors: These prevent the release of viral genetic material inside the host cell.
  • Interferons: These boost the immune response to viral infections.
Biological Properties

Antiviral agents exhibit various biological properties, including their ability to inhibit viral replication, modulate immune responses, and interact with viral proteins . Their expression patterns and tissue distribution can vary depending on the specific antiviral and the target virus. For instance, some antivirals are designed to be active in respiratory tissues to combat respiratory viruses, while others may target liver tissues for hepatitis viruses.

Biological Functions

The primary biological functions of antiviral agents include:

  • Inhibiting Viral Replication: By interfering with the viral life cycle at various stages, antivirals prevent the virus from multiplying .
  • Modulating Immune Responses: Some antivirals enhance the body’s natural immune response to viral infections .
  • Pathogen Recognition: Antivirals can aid in the recognition and elimination of viral pathogens by the immune system .
Modes of Action

Antiviral agents operate through several mechanisms :

  • Blocking Viral Entry: Preventing the virus from binding to and entering host cells.
  • Inhibiting Viral Uncoating: Preventing the release of viral genetic material inside the host cell.
  • Inhibiting Viral Replication: Disrupting the synthesis of viral DNA or RNA.
  • Inhibiting Viral Protein Synthesis: Preventing the production of viral proteins necessary for replication.
  • Inhibiting Viral Assembly and Release: Preventing the assembly of new viral particles and their release from the host cell.
Regulatory Mechanisms

The expression and activity of antiviral agents are regulated through various mechanisms :

  • Transcriptional Regulation: The process by which the transcription of antiviral genes is controlled.
  • Post-Translational Modifications: Chemical modifications of antiviral proteins that affect their activity and stability.
  • Innate Immune Signaling: Modulation of pattern recognition receptors (PRRs) and other immune signaling pathways to enhance antiviral responses.
Applications

Antiviral agents have numerous applications in biomedical research, diagnostics, and therapeutics :

  • Biomedical Research: Studying the mechanisms of viral infections and developing new antiviral drugs.
  • Diagnostic Tools: Detecting viral infections through various assays and tests.
  • Therapeutic Strategies: Treating viral infections such as HIV, hepatitis, influenza, and COVID-19.
Role in the Life Cycle

Antiviral agents play a crucial role throughout the viral life cycle :

  • Development: Preventing the initial establishment of viral infections.
  • Aging: Managing chronic viral infections that may persist throughout life.
  • Disease: Treating acute viral infections and preventing complications.
© Copyright 2024 Thebiotek. All Rights Reserved.